MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.

by Haitao Xu, Liang Zhao, Qiuju Fang, Jianmin Sun, Songyan Zhang, Chao Zhan, Shujie Liu, Yubao Zhang
Published 2014-01-01